Intelligence Driven Advisers LLC Makes New Investment in UnitedHealth Group Incorporated $UNH

Intelligence Driven Advisers LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, HoldingsChannel reports. The firm bought 651 shares of the healthcare conglomerate’s stock, valued at approximately $203,000.

Other large investors have also recently bought and sold shares of the company. Brighton Jones LLC boosted its holdings in shares of UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its stake in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Two Sigma Advisers LP acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $14,063,000. Woodline Partners LP acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $26,637,000. Finally, Williams Jones Wealth Management LLC. raised its stake in UnitedHealth Group by 3.3% in the fourth quarter. Williams Jones Wealth Management LLC. now owns 53,704 shares of the healthcare conglomerate’s stock valued at $27,167,000 after buying an additional 1,703 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 2.4%

NYSE:UNH opened at $339.57 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The firm’s 50 day simple moving average is $293.51 and its 200 day simple moving average is $367.23. The company has a market cap of $307.54 billion, a PE ratio of 14.71, a P/E/G ratio of 2.27 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on UNH. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. HSBC reiterated a “reduce” rating and issued a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. KeyCorp cut their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Cantor Fitzgerald reissued an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.